Clinical Trials

Accrual Status
Limit to SWOG Trials

1032 Results

View
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
SWOG-9455

A Phase II Study of 5-FU Infusion and Alpha Interferon for Treatment of Advanced or Recurrent Metastatic Adenocarcinoma of the Bladder
Research Committee(s)
Genitourinary Cancer
Activated
11-15-1996
Closed
12-01-1998
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
S9628

Phase II Study of Dexamethasone/Alpha Interferon In AL Amyloidosis
Research Committee(s)
Myeloma
Activated
11-01-1996
Closed
03-15-2003
Closed
Phase
Accrual
78%
Published
SWOG Clinical Trial Number
SWOG-9510

Evaluation of Topotecan in Hormone Refractory Prostate Cancer, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
11-01-1996
Closed
08-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9617

A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML).
Research Committee(s)
Leukemia
Activated
11-01-1996
Closed
09-01-1998
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S9615

Neoadjuvant Hormonal Therapy Prior to Radical Prostatectomy for T1 - 2 Adenocarcinoma of the Prostate, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1996
Closed
07-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9504

A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-1996
Closed
12-01-1998
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
S9618

Phase II Trial of Carboplatin Followed by Dose Intense Paclitaxel, Followed by Maintenance Paclitaxel Therapy in Stage IV Ovarian, Fallopian Tube and Peritoneal Cancers
Activated
10-01-1996
Closed
09-15-1999
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9457

Paclitaxel (Taxol®) and Carboplatin for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
07-15-1996
Closed
04-15-2000
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S9623

A Comparison of Intensive Sequential Chemotherapy using Doxorubicin plus Paclitaxel plus Cyclophosphamide with High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women with >= 4 Involved Axillary Lymph Nodes, Phase III, Intergroup.
Research Committee(s)
Breast Cancer
Activated
07-01-1996
Closed
02-15-2001
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
SWOG-9519

Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Research Committee(s)
Head and Neck Cancer
Activated
06-15-1996
Closed
11-01-1997
Closed
Phase
Accrual
34%
Published
SWOG Clinical Trial Number
SWOG-9460

Phase IIb Randomized Chemoprevention Trial of N-(4-Hydroxyphenyl) Retinamide (4-HPR) in Transitional Cell Bladder Carcinoma
Activated
06-01-1996
Closed
10-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9619

Phase II Trial of Intraperitoneal Cisplatin and Intravenous and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian Cancer, Intergroup
Activated
05-15-1996
Closed
05-15-1998
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-9451

Induction Chemotherapy Followed by Chemoradiation for Organ Preservation in Patients with Advanced Resectable Cancer of the Hypopharynx and Base of Tongue, Phase II
Research Committee(s)
Head and Neck Cancer
Activated
04-12-1996
Closed
12-01-2001
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
SWOG-9518

Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas
Research Committee(s)
Sarcoma
Activated
04-01-1996
Closed
10-15-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9509

A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Vinorelbine and Cisplatin in Untreated Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-01-1996
Closed
01-01-1998
Closed
Phase
SWOG Clinical Trial Number
SWOG-9448

An Investigation of Association Between DNA Adduct Formation With Treatment Response and a Limited Sampling Study of Carboplatin Pharmacokinetics in Previously Untreated Ovarian Cancer Patients Registered to SWOG-9249
Activated
03-15-1996
Closed
07-01-1998
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9521

Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary
Research Committee(s)
Gynecologic Cancer
Activated
03-01-1996
Closed
11-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9407

Evaluation of Oral Estramustine and Oral Etoposide in Patients with Hormone Refractory Adenocarcinoma of the Prostate, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
03-01-1996
Closed
07-01-1996
Closed
Phase
Accrual
15%
SWOG Clinical Trial Number
SWOG-9327

Randomized Phase II Pilot Study of Pentoxifylline (Trental®) and Placebo in Patients with Metastatic Malignancy and Anorexia/Cachexia Syndrome
Activated
02-15-1996
Closed
12-15-1997
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
SWOG-9505

Evaluation of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II
Research Committee(s)
Melanoma
Activated
01-01-1996
Closed
08-15-1997